David A. Fiellin, MD
Professor of Medicine (General Medicine) and of Public Health (Health Policy)
Departments & Organizations
Yale Medical Group
SBIRT Training in Yale Residency Programs
School of Public Health: Secondary Faculty | Center for Interdisciplinary Research on AIDS
Internal Medicine: General Internal Medicine: Primary Care Center, Yale-New Haven Hospital | Play2Prevent
Substance Abuse Research
Research Interests
Substance abuse treatment in primary care and HIV specialty settings; opioid agonist maintenance with methadone and buprenorphine more...
Education
- B.A., Earlham College, 1983
- M.D., Emory University, 1991
Selected Publications
- Sullivan LE, Fiellin DA. Buprenorphine for opioid dependent patients in office practice. Annals of Internal Medicine 2008148-662-670.
- Sullivan LE, Moore BA, Chawarski MC, Pantalon MV, Barry DT, O’Connor PG, Schottenfeld RS, Fiellin DA. Buprenorphine/naloxone treatment in primary care is associated with decreased HIV risk behaviors. Journal of Substance Abuse Treatment 200835:87-92.
- Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug and Alcohol Dependence 200894 (1-3):38-47.
